Journal of Medicinal Chemistry p. 3198 - 3211 (2017)
Update date:2022-08-15
Topics: Product Development Enzyme Experimental Arginine Chemical compound Method Selective inhibitor Catalyzes
Muth, Aaron
Subramanian, Venkataraman
Beaumont, Edward
Nagar, Mitesh
Kerry, Philip
McEwan, Paul
Srinath, Hema
Clancy, Kathleen
Parelkar, Sangram
Thompson, Paul R.
Protein arginine deiminase 2 (PAD2) plays a key role in the onset and progression of multiple sclerosis, rheumatoid arthritis, and breast cancer. To date, no PAD2-selective inhibitor has been developed. Such a compound will be critical for elucidating the
View MoreSuzhou Credit International Trading Co., Ltd
Contact:+86-512-65398039
Address:Qingdeng, Hightech. District, Suzhou
Suzhou Lixin Pharmaceutical Co., Ltd.
Contact:86-512-88169812
Address:21 Tangxi Road, Suzhou New District, Suzhou 215151
Goldwills Pharmaceuticals Co., Ltd.
Contact:0916-2237889 13991621155
Address:North Suburb of Hanzhong city, Shaanxi Province
Hangzhou Bayee Chemical Co.,Ltd.
Contact:+86-571-86990109
Address:No.380, Jiangnan Auenue, Binjiang District, Hangzhou, China
Luojiang Chenming Biological Products Co
Contact:+86 15000297032
Address:GROUP NO.4, HE SHENG VILLAGE, PANLONG TOWN,
Doi:10.3109/14756366.2015.1060482
(2016)Doi:10.1016/S0008-6215(00)80525-X
(1981)Doi:10.1016/j.tetlet.2020.152599
(2020)Doi:10.1016/j.molstruc.2019.127633
(2020)Doi:10.1039/d0gc03912h
(2021)Doi:10.1016/S0040-4020(01)97987-6
(1981)